Tirzepatide
Tirzepatide: Dual-Action Weight Loss & Metabolic Health
Tirzepatide is a dual GLP-1/GIP receptor agonist that significantly enhances weight loss and metabolic health. On average, users experience a 15–22.5% reduction in body weight with the added benefits of improved insulin sensitivity and cardiovascular support.

Tirzepatide – Advanced Weight Loss and Metabolic Health
At Metamorphosis, we offer Tirzepatide, a revolutionary peptide therapy designed to target both GLP-1 and GIP receptors, making it a dual-action treatment that enhances weight loss and metabolic function. This advanced therapy leads to significant weight loss, with patients experiencing an average reduction of 15–22.5% of body weight, surpassing the effectiveness of other GLP-1 treatments such as Semaglutide.
Key benefits of Tirzepatide include:
Greater weight loss compared to Semaglutide
Enhanced insulin sensitivity and improved glucose regulation
Cardiovascular benefits, including improved lipid profiles
Supports overall metabolic health and fat burning
Tirzepatide works by helping regulate appetite, increase energy expenditure, and reduce hunger, providing a comprehensive approach to weight loss and long-term metabolic health.
Monthly Program Includes
1:1 coaching to guide you through your journey
Sample meal plans tailored to support your weight loss goals
Medication support to ensure proper usage and results
To begin treatment, recent blood work (within the last 3–6 months) is required. Outside lab work is accepted.
Unlock the power of dual-action therapy for lasting weight loss and improved metabolic health with Tirzepatide.